Sigma Planning Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,090
Closed -$209K 1144
2019
Q4
$209K Sell
1,090
-162
-13% -$29.2K 0.01% 942
2019
Q3
$211K Sell
1,252
-258
-17% -$42K 0.01% 902
2019
Q2
$253K Sell
1,510
-3,009
-67% -$417K 0.01% 812
2019
Q1
$662K Buy
4,519
+2,502
+124% +$363K 0.04% 430
2018
Q4
$270K Sell
2,017
-719
-26% -$118K 0.02% 647
2018
Q3
$521K Buy
2,736
+130
+5% +$23.9K 0.03% 474
2018
Q2
$435K Buy
2,606
+206
+9% +$33.1K 0.03% 499
2018
Q1
$404K Sell
2,400
-260
-10% -$43.6K 0.03% 499
2017
Q4
$327K Buy
2,660
+1,061
+66% +$190K 0.03% 569
2017
Q3
$328K Buy
1,599
+104
+7% +$24.2K 0.03% 571
2017
Q2
$364K Sell
1,495
-50
-3% -$11.7K 0.03% 506
2017
Q1
$369K Buy
1,545
+260
+20% +$60.5K 0.04% 496
2016
Q4
$270K Buy
1,285
+172
+15% +$35.6K 0.03% 558
2016
Q3
$256K Buy
+1,113
New +$272K 0.03% 567
2016
Q1
Sell
-2,049
Closed -$641K 788
2015
Q4
$641K Sell
2,049
-49
-2% -$14.6K 0.09% 254
2015
Q3
$570K Sell
2,098
-124
-6% -$38.1K 0.09% 260
2015
Q2
$674K Sell
2,222
-662
-23% -$197K 0.09% 254
2015
Q1
$859K Sell
2,884
-1,673
-37% -$477K 0.11% 220
2014
Q4
$1.17M Buy
+4,557
New +$1.14M 0.16% 156

Other funds holding AGN

Sigma Planning Corp's AGN Position: Q1 2020 in Review

Sigma Planning Corp sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,090 shares — an estimated $209K sold.

Sigma Planning Corp first reported a position in AGN in Q4 2014 and held it in 19 quarters. The position peaked at $1.17M in Q4 2014. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Sigma Planning Corp reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Sigma Planning Corp sold 1,090 Allergan plc shares in Q1 2020, an estimated $209K.
  • Sigma Planning Corp first reported a position in Allergan plc in Q4 2014 and held it in 19 quarters.
  • Sigma Planning Corp's Allergan plc position peaked at $1.17M in Q4 2014.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Sigma Planning Corp's 13F filing for Q1 2020, filed 1 May 2020.